arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Author

Steven Whitebread

9 papers · 2007–2020

2007: 22008: 12009: 32010: 02011: 02012: 02013: 02014: 22015: 02016: 02017: 02018: 02019: 02020: 1
2007peak 3 in 20092020

Frequent co-authors

Papers

showing 1–9 of 9 RSS

Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure

Andreas Bender, Josef Scheiber, Meir Glick +6 more

Computational Theory and Mathematics · ChemMedChem · · cited 326× · DOI ↗ · more like this ·

Preclinical Safety Pharmacology (PSP) attempts to anticipate adverse drug reactions (ADRs) during early phases of drug discovery by testing compounds in simple, in vitro binding assays (that is, preclinical profiling). The selection of PSP targets is based largely on circumstantial evidence of their contribution to known clinical ADRs, inferred from findings in clinical trials, animal experiments, and molecular studies going back more than forty years. In this work we explore PSP chemical space and its relevance for the prediction of adverse drug reactions. Firstly, in silico (computational) Bayesian models for 70 PSP-related targets were built, which are able to detect 93% of the ligands binding at IC(50) < or = 10 microM at an overall correct classification rate of about 94%. Secondly, employing the World Drug Index (WDI), a model for adverse drug reactions was built directly based on…

Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data

Khalil Azzaoui, Jacques Hamon, Bernard Faller +5 more

Computational Theory and Mathematics · ChemMedChem · · cited 177× · DOI ↗ · more like this ·

This study describes a method for mining and modeling binding data obtained from a large panel of targets (in vitro safety pharmacology) to distinguish differences between promiscuous and selective compounds. Two naïve Bayes models for promiscuity and selectivity were generated and validated on a test set as well as publicly available drug databases. The model shows a higher score (lower promiscuity) for marketed drugs than for compounds in early development or compounds that failed during clinical development. Such models can be used in triaging high-throughput screening data or for lead optimization.

Mapping Adverse Drug Reactions in Chemical Space

Josef Scheiber, Jeremy L. Jenkins, Sai Chetan K. Sukuru +9 more

Computational Theory and Mathematics · Journal of Medicinal Chemistry · · cited 159× · DOI ↗ · more like this ·

We present a novel method to better investigate adverse drug reactions in chemical space. By integrating data sources about adverse drug reactions of drugs with an established cheminformatics modeling method, we generate a data set that is then visualized with a systems biology tool. Thereby new insights into undesired drug effects are gained. In this work, we present a global analysis linking chemical features to adverse drug reactions.

Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis

Josef Scheiber, Bin Chen, Mariusz Milik +9 more

Computational Theory and Mathematics · Journal of Chemical Information and Modeling · · cited 154× · DOI ↗ · more like this ·

We present a workflow that leverages data from chemogenomics based target predictions with Systems Biology databases to better understand off-target related toxicities. By analyzing a set of compounds that share a common toxic phenotype and by comparing the pathways they affect with pathways modulated by nontoxic compounds we are able to establish links between pathways and particular adverse effects. We further link these predictive results with literature data in order to explain why a certain pathway is predicted. Specifically, relevant pathways are elucidated for the side effects rhabdomyolysis and hypotension. Prospectively, our approach is valuable not only to better understand toxicities of novel compounds early on but also for drug repurposing exercises to find novel uses for known drugs.

The activities of drug inactive ingredients on biological targets

Joshua Pottel, Duncan Armstrong, Ling Zou +9 more

Computational Theory and Mathematics · Science · · cited 88× · DOI ↗ · more like this ·

Inactive ingredients may not be inert Most drug formulations comprise mainly inactive ingredients known as excipients. Excipients are tested in animal studies and do not display toxicity at allowed concentrations, but their interaction with molecular targets has not been systematically explored. Pottel et al. examined excipient activity by combining large-scale computational screening with targeted experimental testing. They identified 38 excipients with activities against 44 targets. Several excipients were active in cell panels that predict tissue-level toxicity, and two are suggested to reach concentrations in vivo that overlap with their in vitro activities. Although most excipients are inert, some have activity that deserves further consideration. Science , this issue p. 403

Matched Molecular Pair Analysis: Significance and the Impact of Experimental Uncertainty

Christian Krämer, Julian E. Fuchs, Steven Whitebread +2 more

Computational Theory and Mathematics · Journal of Medicinal Chemistry · · cited 76× · DOI ↗ · more like this ·

Matched molecular pair analysis (MMPA) has become a major tool for analyzing large chemistry data sets for promising chemical transformations. However, the dependence of MMPA predictions on data constraints such as the number of pairs involved, experimental uncertainty, source of the experiments, and variability of the true physical effect has not yet been described. In this contribution the statistical basics for judging MMPA are analyzed. We illustrate the connection between overall MMPA statistics and individual pairs with a detailed comparison of average CHEMBL hERG MMPA results versus pairs with extreme transformation effects. Comparing the CHEMBL results to Novartis data, we find that significant transformation effects agree very well if the experimental uncertainty is considered. This indicates that caution must be exercised for predictions from insignificant MMPAs, yet…

A Screening Pattern Recognition Method Finds New and Divergent Targets for Drugs and Natural Products

Anne Mai Wassermann, Eugen Lounkine, László Urbán +8 more

Computational Theory and Mathematics · ACS Chemical Biology · · cited 44× · DOI ↗ · more like this ·

Computational target prediction methods using chemical descriptors have been applied exhaustively in drug discovery to elucidate the mechanisms-of-action (MOAs) of small molecules. To predict truly novel and unexpected small molecule-target interactions, compounds must be compared by means other than their chemical structure alone. Here we investigated predictions made by a method, HTS fingerprints (HTSFPs), that matches patterns of activities in experimental screens. Over 1,400 drugs and 1,300 natural products (NPs) were screened in more than 200 diverse assays, creating encodable activity patterns. The comparison of these activity patterns to an MOA-annotated reference panel led to the prediction of 5,281 and 2,798 previously unknown targets for the NP and drug sets, respectively. Intriguingly, there was limited overlap among the targets predicted; the drugs were more biased toward…

Side effect profile prediction - early addressing of big pharma's worst nightmare

Josef Scheiber, James L. Jenkins, Andreas Bender +6 more

Computational Theory and Mathematics · Chemistry Central Journal · · cited 28× · DOI ↗ · more like this ·

Adverse effects of drugs that are only identified after a compound enters the clinic seriously limit therapeutic potential and could result in withdrawal from the market.Two well-known examples in recent years were Rofecoxib (Vioxx®) and Cerivastatin (Baycol®, Lipobay®), but there are many other examples.Avoiding such adverse effects is therefore a key goal in drug discovery.

SPREAD—exploiting chemical features that cause differential activity behavior

Josef Scheiber, Jeremy L. Jenkins, Andreas Bender +8 more

Computational Theory and Mathematics · Statistical Analysis and Data Mining The ASA Data Science Journal · · cited 1× · DOI ↗ · more like this ·

Abstract We present a novel generic method to better understand the divergent activities of molecules that often occur in orthogonal assays. The newly developed simple prediction of activity differences (SPREAD) method directly aims to model and understand the differences compounds exhibit when tested in two or more assays. By transforming the activity values from the assays into meta‐categories (specifically defined for datasets under scrutiny), statistical models can be trained directly on the qualitative differences between assays. This contributes heavily toward a tangible understanding of molecular assay selectivity. Although ensembles of models could be used alternatively to predict compounds that score highly in one assay and low in another, the advantage of the SPREAD approach is that the chemical features influencing assay differences are parsed out immediately as a consequence…